G-NiiB Oral Microbiome Immunity Formula SIM01 Alleviates Post-COVID-19 Conditions
- Written by Reporters
Clinical Study Published in the Prestigious International Medical Journal The Lancet Infectious Diseases
HONG KONG SAR - Media OutReach Newswire - 8 December 2023 - Hong Kong's leading biomedical and microbiome technology company, G-NiiB GenieBiome, is pleased to announce that a ground-breaking large-scale randomised, double-blind,...Read more: G-NiiB Oral Microbiome Immunity Formula SIM01 Alleviates Post-COVID-19 Conditions